Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
9
90%
Ph not_applicable
1
10%

Phase Distribution

9

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution10 total trials
Phase 1Safety & dosage
9(90.0%)
N/ANon-phased studies
1(10.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

10

all time

Status Distribution
Completed(1)
Other(9)

Detailed Status

unknown9
Completed1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
0
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 19 (90.0%)
N/A1 (10.0%)

Trials by Status

unknown990%
completed110%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
RADIATION
Total Trials
10